Investor RelationsCOVID-19
  1. Home
  2. Medical Imaging
  3. Molecular Imaging
Biograph Vision

Molecular Imaging

Answering to clinical needs in oncology, neurology, cardiology, and radiology, Siemens Healthineers Molecular Imaging systems provide PET/CT, SPECT, and hybrid SPECT scanner (SPECT/CT) solutions to help clinicians diagnose, treat, and monitor disease more confidently.

Nuclear Medicine News & Stories

By Takeshi Shimizu, PhD

Image-based selection of Alzheimer’s disease therapy
 2022-11-30
PET imaging and emerging immunotherapy candidates are beginning to enable image-based therapy personalization for dementia.
Healthcare Trends

By Catherine Marcic Joyce

EANM’s 35th congress reunites nuclear medicine industry
 2022-11-29
Barcelona, Spain, welcomed attendees from around the globe as they assembled in person for the European Association of Nuclear Medicine’s 35th Annual Congress.
News

By Claudette Lew

Whole-body parametric imaging expands clinical opportunities

 2022-10-05
A team at Aarhus University Hospital in Denmark validates the clinical potential value of routine whole-body parametric imaging with PET/CT.

By Florian Bayer

Advances in PSMA-based approach for prostate cancer
 2022-09-13
Nuclear medicine, urology, and biomedical engineering experts discuss a new PSMA-based approach that combines diagnosis and therapeutics for the treatment of prostate cancer.
Healthcare Trends
Claudette Lew
SNMMI 2022 annual meeting showcases the future of nuclear medicine
 2022-09-12
Siemens Healthineers hosts booth and a luncheon symposium and launches new product at SNMMI 2022.
News
* Biograph Vision is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
1
syngo.PET Amyloid Plaque is intended for use only with approved amyloid radiopharmaceuticals in the country of use. Users should review the drug labeling for approved uses.